Biocept Forecast and Stock Analysis
Technical BIOC stock analysis for Friday May 24, 2019.
|Price to book||USD 1.75|
|Next Earnings Date||2019-08-13|
No changes to the price of Biocept in the last trading day ( Friday, 24th May 2019 ). During day the stock fluctuated 0.00% from a day low at $1.13 to a day high of $1.13. The price has fallen in 7 of the last 10 days , but is still up by 23.93% over the past 2 weeks.
- 30 day high of the BIOC stock price was $2.11 and low was $0.78.
- 90 day high was $2.11 and low was $0.78.
- 52 week high for the Biocept - $12.15 and low - $0.14.
Biocept lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.41% during the next 3 months and, with 90% probability hold a price between $0.75 and $1.49 at the end of this period.
Biocept holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $1.18. On a fall, the stock will find some support from the long-term average at approximately $1.01. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Thursday May 23, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 57 and the stock is currently not being overbought or oversold
Support & Resistance
Biocept finds support from accumulated volume at $1.08.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 0.00%. For the last week the stock has had a daily average volatility of 26.70%.
Our recommended stoploss: $1.06 (-5.86%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)
26.70 %Average volatility
Very Low Low Medium High Very High
Biocept holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|BIOC $1.13 ($0.00 0.00%)|
BIOC is down $0.00 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for BIOC based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the BIOC analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us